ArticleAdvances in urology2018

Efficacy of Transdermal Oxybutynin in the Treatment of Overactive Bladder Syndrome: Does It Make Sense Using It in 2017?

Raúl Vozmediano-Chicharro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.